(PRESS RELEASE) FREIBURG, Germany, 1-Jul-2021 — /EuropaWire/ — Prostate cancer is the second most common cancer. According to the American Cancer Association, 1 in every 8 men will be diagnosed with it in their lifetime. In 2018 around 1.2 million … Read the full press release →
Posted in Business, Germany, Healthcare, Investment, News, Pharma & Biotech, Science
Tagged American Cancer Association, B66, bioscience, Biotech, bladder, breast, Cancer, colorectal, Dr Eric Metzger, Freiburg, Germany, histone methyltransferase, inhibitors, KMT9, lung cancer, Manfred Jung, Mike Dunckley, pharma, Professor Manfred Jung, Professor Roland Schule, Professors Roland Schule, prostate cancer, prostate tumours, University of Freiburg